DrugPatentWatch Database Preview
Qilu Company Profile
» See Plans and Pricing
What is the competitive landscape for QILU, and what generic and branded alternatives to QILU drugs are available?
QILU has nineteen approved drugs.
There are three tentative approvals on QILU drugs.
Summary for Qilu
| US Patents: | 0 |
| Tradenames: | 16 |
| Ingredients: | 16 |
| NDAs: | 19 |
Drugs and US Patents for Qilu
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Qilu | IRINOTECAN HYDROCHLORIDE | irinotecan hydrochloride | INJECTABLE;INJECTION | 203380-001 | May 3, 2016 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Qilu | OXALIPLATIN | oxaliplatin | INJECTABLE;INTRAVENOUS | 204616-002 | May 11, 2016 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Qilu | OLMESARTAN MEDOXOMIL | olmesartan medoxomil | TABLET;ORAL | 210552-003 | Jan 10, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Qilu | CEFTRIAXONE | ceftriaxone sodium | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | 203702-001 | Jun 29, 2016 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Qilu | TADALAFIL | tadalafil | TABLET;ORAL | 210420-004 | Mar 26, 2019 | AB1 | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
